Waist circumference, visceral obesity, and cardiovascular risk

Journal of Cardiopulmonary Rehabilitation

Volumn 23, Issue 3, 2003, Pages 161-169

  Poirier, Paul ^a   Després, Jean Pierre ^b  

^a LAVAL UNIVERSITY   (Canada)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADAPTATION; ANTHROPOMETRIC PARAMETERS; ATHEROSCLEROSIS; BEHAVIOR THERAPY; BODY FAT; BODY WEIGHT; CARDIOVASCULAR RISK; CELL DAMAGE; CHOLESTEROL BLOOD LEVEL; COMORBIDITY; DISABILITY; EDUCATION PROGRAM; ENDOTHELIUM CELL; EPIDEMIC; EPIDEMIOLOGICAL DATA; EXERCISE; GLUCOSE BLOOD LEVEL; HEALTH BEHAVIOR; HEALTH CARE COST; HEALTH EDUCATION; HEART FUNCTION; HIGH RISK POPULATION; HUMAN; LIFESTYLE; LONG TERM CARE; OBESITY; PHYSICAL ACTIVITY; PREVALENCE; REVIEW; TRAINING; WALKING; WEIGHT GAIN; WEIGHT REDUCTION;

ADIPOSE TISSUE; ARTERIOSCLEROSIS; BODY CONSTITUTION; CARDIOVASCULAR DISEASES; HUMANS; OBESITY; RISK FACTORS; WEIGHT LOSS;

EID: 0037605880     PISSN: 08839212     EISSN: None     Source Type: Journal    
DOI: 10.1097/00008483-200305000-00001     Document Type: Review

References (115)

1. Poirier P, Eckel RH. The heart and obesity. In: Fuster V, Alexander RW, King S, O'Rourke RA, Roberts R, Wellens HJJ, eds. Hurst's The Heart. 10th ed. New York: McGraw-Hill; 2000:2289-2303.
2. Wilson PW, D'Agostino RB, Sullivan L, Parise H, Kannel WB. Overweight and obesity as determinants of cardiovascular risk: the Framingham experience. Arch Intern Med. 2002;162:1867-1872.
3. Eckel RH, Barouch WW, Ershow AG. Report of the National Heart, Lung, and Blood Institute-National Institute of Diabetes and Digestive and Kidney Diseases Working Group on the pathophysiology of obesity-associated cardiovascular disease. Circulation. 2002;105:2923-2928.
4. Drenick EJ, Bale GS, Seltzer F, Johnson DG. Excessive mortality and causes of death in morbidly obese men. JAMA. 1980;243:443-445.
5. Poirier P, Eckel RH. Obesity and cardiovascular disease. Curr Atheroscler Rep. 2002;4:448-453.
6. Kumanyika S, Jeffery RW, Morabia A, Ritenbaugh C, Antipatis VJ. Obesity prevention: the case for action. Int J Obes Relat Metab Disord. 2002;26:425-436.
7. Eckel RH, Krauss RM. American Heart Association call to action: obesity as a major risk factor for coronary heart disease. AHA Nutrition Committee. Circulation. 1998;97:2099-2100.
8. Eckel RH. Obesity and heart disease: a statement for healthcare professionals from the Nutrition Committee, American Heart Association. Circulations. 1997;96:3248-3250.
9. VanItallie TB. Prevalence of obesity. Endocrinol Metab Clin North Am. 1996;25:887-905.
10. Clinical Guidelines on the Identification, Evaluation, and Treatment of Overweight and Obesity in Adults: The Evidence Report. National Institutes of Health. Obes Res. 1998;(suppl 2):51S-209S.
11. Lappalainen R, Tuomisto MT, Giachetti I, D'Amicis A, Paquet S. Recent body weight changes and weight loss practices in the European Union. Public Health Nutrition. 2000;2:135-141.
12. Katzmarzyk PT. The Canadian obesity epidemic: an historical perspective. Obes Res. 2002;10:666-674.
13. Torrance GM, Hooper MD, Reeder BA. Trends in overweight and obesity among adults in Canada (1970-1992): evidence from national surveys using measured height and weight. Int J Obes Relat Metab Disord. 2002:26:797-804.
14. Eisenstein EL, Shaw LK, Nelson CL, Anstrom KJ, Hakim Z, Mark DB. Obesity and long-term clinical and economic outcomes in coronary artery disease patients. Obes Res. 2002;10:83-91.
15. Gruberg L, Weissman NJ, Walksman R, et al. The impact of obesity on the short-term and long-term outcomes after percutaneous coronary intervention: the obesity paradox? J Am Coll Cardiol. 2002;39:578-584.
16. Mehta LS, Skelding KA, Grines LL, Boura JA, Grines CL, Obesity: protective in acute myocardial infarction patients? Circulation. 2002;106(suppl II):402.
17. Bader DS, Maguire TE, Spahn CM, O'Malley CJ, Balady GJ. Clinical profile and outcomes of obese patients in cardiac rehabilitation stratified according to National Heart, Lung, and Blood Institute criteria. J Cardiopulm Rebabil. 2001;21:210-217.
18. Desprès JP, Lemieux I, Prud'homme D. Treatment of obesity: need to focus on high-risk abdominally obese patients. BMJ. 2001;322:716-720.
19. Desprès JP. Abdominal obesity and the risk of coronary artery disease. Can J Cardiol. 1992;8:561-562.
20. Reeder BA, Senthilselvan A, Desprès JP, et al. The association of cardiovascular disease risk factors with abdominal obesity in Canada. Canadian Heart Health Surveys Research Group. CMAJ. 1997;157(suppl 1):S39-S45.
21. Buemann B, Tremblay A. Effects of exercise training on abdominal obesity and related metabolic complications. Sports Med. 1996;21:191-212.
22. Kohrt WM, Kirwan JP, Staten MA, Bourey RE, King DS, Holloszy JO. Insulin resistance in aging is related to abdominal obesity. Diabetes. 1993;42:273-281.
23. Tchernof A, Nolan A, Sites CK, Ades PA, Poehlman ET. Weight loss reduces C-reactive protein levels in obese postmenopausal women. Circulation. 2002;105:564-569.
24. Nakanishi N, Sato M, Shirai K, et al. Associations between white blood cell count and features of the metabolic syndrome in Japanese male office workers. Ind Health. 2002;40:273-277.
25. Perez-Martin A, Dumortier M, Pierrisnard E, Raynaud E, Mercier J, Brun JF. Multivariate analysis of relationships between insulin sensitivity and blood theology: is plasma viscosity a marker of insulin resistance? Clin Hemorheol Microcirc. 2001;25:91-103.
26. Cottam DR, Schaefer PA, Fahmy D, Shaftan GW, Angus LD. The effect of obesity on neutrophil Fc receptors and adhesion molecules (CD16, CD11b, CD62L). Obes Surg. 2002;12:230-235.
27. Ridker PM. Novel risk factors and markers for coronary disease. Adv Intern Med. 2000;45:391-418.
28. Lakka HM, Lakka TA, Tuomilehto J, Salonen JT. Abdominal obesity is associated with increased risk of acute coronary events in men. Eur Heart J. 2002;23:706-713.
29. Bogaty P, Robitaille NM, Solymoss S, et al. Atherogenic, hemostatic, and other potential risk markers in subjects with previous isolated myocardial infarction compared with long-standing uncomplicated stable angina. Am Heart J. 1998;136:884-893.
30. Bogaty P, Poirier P, Simard S, Boyer L, Solymoss S, Dagenais GR. Biological profiles in subjects with recurrent acute coronary events compared with subjects with long-standing stable angina. Circulation. 2001;103:3062-3068.
31. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA. 2001;285:2486-2497.
32. Zhu S, Wang Z, Heshka S, Heo M, Faith MS, Heymsfield SB. Waist circumference and obesity-associated risk factors among whites in the third National Health and Nutrition Examination Survey: clinical action thresholds. Am J Clin Nutr. 2002;76:743-749.
33. Janssen I, Katzmarzyk PT, Ross R. Body mass index, waist circumference, and health risk: evidence in support of current National Institutes of Health guidelines. Arch Intern Med. 2002;162:2074-2079.
34. Larsson B, Svardsudd K, Welin L, Wilhelmsen L, Bjorntorp P, Tibblin G. Abdominal adipose tissue distribution, obesity, and risk of cardiovascular disease and death: 13-year follow-up of participants in the study of men born in 1913. BMJ. 1984;288:1401-1404.
35. Folsom AR, Kaye SA, Sellers TA, et al. Body fat distribution and 5-year risk of death in older women. JAMA. 1993;269:483-487.
36. Rexrode KM, Carey VJ, Hennekens CH, et al. Abdominal adiposity and coronary heart disease in women. JAMA. 1998;280:1843-1848.
37. Lemieux I, Pascot A, Couillard C, et al. Hypertriglyceridemic waist: a marker of the atherogenic metabolic triad (hyperinsulinemia; hyperapolipoprotein B; small, dense LDL) in men? Circulation. 2000;102:179-184.
38. Tchernof A, Lamarche B, Prud'homme D, et al. The dense LDL phenotype: association with plasma lipoprotein levels, visceral obesity, and hyperinsulinemia in men. Diabetes Care. 1996;19:629-637.
39. Couillard C, Bergeron N, Prud'homme D, et al. Postprandial triglyceride response in visceral obesity in men. Diabetes. 1998;47:953-960.
40. Pascot A, Lemiettx I, Prud'homme D, et al. Reduced HDL particle size as an additionai feature of the atherogenic clyslipidemia of abdominal obesity. J Lipid Res. 2001;42:2007-2014.
41. Leieux S, DesprÈs JP. Metabolic complications of visceral obesity: contribution to the aetiology of type 2 diabetes and implications for prevention and treatment. Diabetes Metab. 1994;20:375-393.
42. Juhan-Vague I, Alessi MC. PAI-1, obesity, insulin resistance, and risk of cardiovascular events. Thromb Haemost. 1997;78:656-660.
43. Yudkin JS, Stehotlwer CD, Emeis JJ, Coppack SW. C-reactive protein in healthy subjects: associations with obesity, insulin resistance, and endothelial dysfunction: a potentiai role for cytokines originating from adipose tissue? Arterioscler Thromb Vasc Biol. 1999;19:972-978.
44. Hak AE, Stehouwer CD, Bots ML, et al. Associations of C-reactive protein with measures of obesity, insulin resistance, and subclinical atherosclerosis in healthy, middle-aged women. Arterioscler Thromb Vasc Biol. 1999;19:1986-1991.
45. Yudkin JS, Kumari M, Humphries SE, Mohamed-Ali V. Inflammation, obesity, stress, and coronary heart disease: is interleukin-6 the link? Atherosclerosis. 2000;148:209-214.
46. Pascot A, Poirier P, Lemieux I, Desprès JP. Caractère distinct de la plaque athèromateuse du patient insulino-rèsistant diabètique. Arm Endocrinol (Paris). 2002;62:267-273.
47. Folsom AR, Qamhieh HT, Wing RR, et al. Impact of weight loss on plasminogen activator inhibitor (PAI-1), factor VII, and other hemostatic factors in moderately overweight adults. Arteioscler Thromb. 1993;13:162-169.
48. Cigolini M, Targher G, Bergamo AJ, Tonoli M, Agostino G, De Sandre G. Visceral fat accumulation and its relation to plasma hemostatic factors in healthy men. Arterioscler Thromb Vasc Biol. 1996;16:368-374.
49. Svendsen OL, Hassager C, Christiansen C, Nielsen JD, Winther K. Plasminogen activator inhibitor-1, tissue-type plasminogen activator, and fibrinogen: effect of dieting with or without exercise in overweight postmenopausal women. Arterioscler Thromb Vasc Biol. 1996;16:381-385.
50. Licata G, Scaglione R, Avellone G, et al. Hemostatic function in young subjects with central obesity: relationship with left ventricular function. Metabolism. 1995;44:1417-1421.
51. Steinberg HO, Chaker H, Learning R, Johnson A, Brechtel G, Baron AD. Obesity/insulin resistance is associated with endothelial dysfunction: implications for the syndrome of insulin resistance. J Clin Invest. 1996;97:2601-2610.
52. Hashimoto M, Akishita M, Eto M, et al. The impairment of flow-mediated vasodilatation in obese men with visceral fat accumulation. Int J Obex Relat Metab Disord. 1998;22:477-484.
53. Grundy SM. Obesity, metabolic syndrome, and coronary atherosclerosis. Circulation, 2002;105:2696-2698.
54. Cornier MA, Tare CW, Grunwald GK, Bessesen DH. Relationship between waist circumference, body mass index, and medical care costs. Obes Res. 2002;10:1167-1172.
55. Alberti KG, Zimmet PZ. Definition, diagnosis, and classification of diabetes mellitus and its complications: Part 1. Diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med. 1998;15:539-553
56. Isomaa B, Almgren P. Tuomi T. et al. Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care. 2001;24:683-689.
57. Haffner SM, D'Agostino R Jr, Mykkanen L, et al. Insulin sensitivity in subjects with type 2 diabetes: relationship to cardiovascular risk factors. The insulin Resistance Atherosclerosis Study. Diabetes Care. 1999;22:562-568.
58. Ford ES, Giles WH, Dietz WH. Prevalence of the metabolic syndrome among US adults: findings from the Third National Health and Nutrition Examination Survey. JAMA. 2002;287:356-359.
59. Lakka TA, Lakka HM, Salonen R, Kaplan GA, Salonen JT. Abdominal obesity is associated with accelerated progression of carotid atherosclerosis in men. Atherosclerosis. 2001;154:497-504.
60. Lamarche B, Lemieux I, DesprÈs JP. The small, dense LDL phenotype and the risk of coronary heart disease: epidemiology, pathophysiology, and therapeutic aspects. Diabetes Metab. 1999;25:199-211.
61. Balkau B, Shipley M, Jarrett RJ, et al. High blood glucose concentration is a risk factor for mortality in middle-aged nondiabetic men: 20-year follow-up in the Whitehall Study, the Paris Prospective Study, and the Helsinki Policemen Study. Diabetes Care. 1998;21:360-367.
62. Meigs JB, Nathan DM, D'Agostino RB Sr, Wilson PW. Fasting and postchallenge glycemia and cardiovascular disease risk: the Framingham offspring study. Diabetes Care. 2002;25:1845-1850.
63. St Pierre J, Lemieux I, Vohl MC, et al. Contribution of abdominal obesity and hypertriglyceridemia to impaired fasting glucose and coronary artery disease. Am J Cardiol. 2002;90:15-18.
64. Pratley RE, Hagberg JM, Dengel DR, Rogus EM, Muller DC, Goldberg AP. Aerobic exercise training-induced reductions in abdominal fat and glucose-stimulated insulin responses in middle-aged and older men. J Am Geriatr Soc 2000;48:1055-1061.
65. Ross R, Dagnone D, Jones PJH, et al. Reduction in obesity and related comorbid conditions after diet-induced weight loss or exercise-induced weight loss in men: a randomized, controlled trial. Ann Intern Med. 2000;133:92-103.
66. Tremblay A, Nadeau A, Desprès JP, St-Jean L, Thèriault G, Bouchard C. Long-term exercise training with constant energy intake: 2. Effect on glucose metabolism and resting energy expenditure. Int J Obes. 1990;14:75-84.
67. Desprès JP, Pouliot MC, Moorjani S, et al. Loss of abdominal fat and metabolic response to exercise training in obese women. Am J Physiol. 1991;261:E159-E167.
68. Pouliot MC, Desprès JP, Lemieux S, et al. Waist circumference and abdominal sagittal diameter: best simple anthropometric indexes of abdominal visceral adipose tissue accumulation and related cardiovascular risk in men and women. Am J Cardiol. 1994;73:460-468.
69. Desprès JP, Lamarche B, Mauriège P, et al. Hyperinsulinemia as an independent risk factor for ischemic heart disease. N Engl. J Med. 1996;334:952-957.
70. McGill HC. Fatty streaks in the coronary arteries and aorta. Lab Invest. 1968;18:560-564.
71. Skalen K, Gustafsson M, Rydberg EK, et al. Subendothelial retention of atherogenic lipoproteins in early atherosclerosis. Nature. 2002;417:750-754.
72. Holman RL. Atherosclerosis: a pediatric nutrition problem? Am J Clin Nutr. 1961;9:565-569.
73. McGill HC Jr, McMahan CA, Herderick EE, Malcom GT, Tracy RE, Strong JP. Origin of atherosclerosis in childhood and adolescence. Am J Clin Nutr. 2000;72:1307S-1315S.
74. Berenson GS. Bogalusa Heart Study: a long-term community study of a rural biracial (black/white) population. Am J Med Sci. 2001;322:267-274.
75. Enos WF, Holmes RH, Beyer J. Coronary disease among United States soldiers killed in action in Korea. JAMA. 1953;152:1090-1093.
76. McGill HC Jr, McMahan CA, Malcom GT, Oalm. MC, Strong JP. Relation of glycohemoglobin and adiposity to atherosclerosis in youth: Pathobiologicat Determinants of Atherosclerosis in Youth (PDAY) Research Group. Arterioscler Thromb Vasc Biol. 1995;15:431-440.
77. Zieske AW, Malcom GT, Strong JP. Natural history and risk factors of atherosclerosis in children and youth: the PDAY study. Pediatr Pathol Mol Med. 2002;21:213-237.
78. McGill HC Jr, McMahan CA, Herderick EE, et al. Obesity accelerates the progression of coronary atherosclerosis in young men. Circulation. 2002;105:2712-2718.
79. Kannel WB. The Framingham Study: historical insight on the impact of cardiovascular risk factors in men versus women. J Gend Specif Med. 2002;5:27-37.
80. Tchernof A, Poehlman ET, Desprès JP. Body fat distribution, the menopause transition, and hormone replacement therapy. Diabetes Metab. 2000;26:12-20.
81. Ryan AS, Nicklas BJ, Berman DM. Racial differences in insulin resistance and midthigh fat deposition in postmenopausal women. Obes Res. 2002;10:336-344.
82. Rabkin SW, Mathewson FA, Hsu PH. Relation of body weight to development of ischemic heart disease in a cohort of young North American men after a 26-year observation period: the Manitoba Study. Am J Cardiol. 1977;39:452-458.
83. Hubert HB, Feinleib M, McNamara PM, Castelli WP. Obesity as an independent risk factor for cardiovascular disease: a 26-year follow-up of participants in the Framingham Heart Study. Circulation. 1983;67:968-977.
84. Amos AF, McCarty DJ, Zimmet P. The rising global burden of diabetes and its complications: estimates and projections to the year 2010. Diabet Med. 1997;14:S1-S85.
85. Eriksson KF, Lindgarde F. Prevention of type 2 (non-insulin-dependent) diabetes mellitus by diet and physical exercise. The 6-year Malmo feasibility study. Diabetologia. 1991;34:891-898.
86. Tuomilehto J, Lindstrom J, Eriksson JG, et al. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Eng J Med. 2001;344:1343-1350.
87. Knowler WC, Barrett-Connor E, Fowler SE, et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med. 2002;346:393-403.
88. Lee CD, Blair SN, Jackson AS. Cardiorespiratory fitness, body composition, and all-cause and cardiovascular disease mortality in men. Am J Clin. Nutr. 1999;69:373-380.
89. Wei M, Gibbons LW, Kampert JB, Nichaman MZ, Blair SN. Low cardiorespiratory fitness and physical inactivity as predictors of mortality in men with type 2 diabetes. Ann Intern Med. 2000;132:605-621.
90. Prevalence of leisure-time physical activity among overweight adults: United States, 1998. MMWR Morb Mortal Wkly Rep. 2000;49:326-330.
91. Pate RR, Pratt M, Blair SN, et al. Physical activity and public health: a recommendation from the Centers for Disease Control and Prevention and the American College of Sports Medicine. JAMA. 1995;273:402-407.
92. Poirier P, Desprès JP. Exercise in weight management of obesity. Cardiol Clin 2001;19:459-470.
93. Mattsson E, Larsson UE, Rossner S. Is walking for exercise too exhausting for obese women? Int J Obes Relat Metab Disord. 1997;21:380-386.
94. Kraus WE, Hournard JA, Duscha BD, et al. Effects of the amount and intensity of exercise on plasma lipoproteins. N Engl J Med. 2002;347:1483-1492.
95. Tremblay A, Desprès JP, Maheux J, et al. Normalization of the metabolic profile in obese women by exercise and a low fat diet. Med Sci Sports Exerc. 1991;23:1326-1331.
96. Wood PD, Stefanick ML, Dreon DM, et al. Changes in plasma lipids and lipoproteins in overweight men during weight loss through dieting as compared with exercise. N Engl J Med. 1988;319:1173-1179.
97. Poirier P, Catellier C, Tremblay A, Nadeau A. Role of body fat loss in the exercise-induced improvement of the plasma lipid profile in non-insulin-dependent diabetes mellitus. Metabolism. 1996;45:1383-1387.
98. Walker KZ, Piers LS, Putt RS, Jones JA, O'Dea K. Effects of regular walking on cardiovascular risk factors and body composition in normoglycemic women and women with type 2 diabetes. Diabetes Care. 1999;22:555-561.
99. Wadden TA, Foster GD, Letizia KA. One-year behavioral treatment of obesity: comparison of moderate and severe caloric restriction and the effects of weight maintenance therapy. J Consult Clin Psychol. 1994;62:165-171.
100. Executive summary of the clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults. Arch Intern Med. 1998;158:1855-1867.
101. Wadden TA. Sternberg JA, Letizia KA, Stunkard AJ, Foster GD. Treatment of obesity by very low calorie diet, behavior therapy, and their combination: a five-year perspective. Int J Obes. 1989;13:39-46.
102. Wadden TA, Stunkard AJ. Controlled trial of very low calorie diet, behavior therapy, and their combination in the treatment of obesity. J Consult Clin Psychol 1986;54:482-488.
103. Perri MG, Nezu AM, Patti ET, McCann KL. Effect of length of treatment on weight loss. J Consult Clin Psychol. 1989;57:450-452.
104. Gu K, Cowie CC, Harris MI. Diabetes and decline in heart disease mortality in US adults. JAMA. 1999;281:1291-1297.
105. Olefsky JM. Prospects for research in diabetes mellitus. JAMA 2001;285:628-632.
106. Galuska DA, Will JC, Serdula MK. Are healthcare professionals advising obese patients to lose weight? JAMA. 1999;282:1576-1578.
107. Wee CC, McCarthy EP, Davis RB, Phillips RS. Physician counseling about exercise. JAMA. 1999;282:1583-1588.
108. Heilbronn LK, Noakes M, Clifton PM. Energy restriction and weight loss on very-low-fat diets reduce C-reactive protein concentrations in obese, healthy women. Arteioscler Thromb Vasc Biol. 2001;21:968-970.
109. Ziccardi P, Nappo F, Giugliano G, et al. Reduction of inflammatory cytokine concentrations and improvement of endothelial functions in obese women after weight loss over one year. Circulation. 2002;105:804-809.
110. Otsuka Y, Miyazaki S, Okumura H, et al. Abnormal glucose tolerance, not small vessel diameter, is a determinant of long-term prognosis in patients treated with balloon coronary angioplasty. Eur Heart J. 2000;21:1790-1796.
111. Korpilahti K, Syvanne M, Engblom E, Hamalainen H, Puukka P, Ronnemaa T. Components of the insulin resistance syndrome are associated with progression of atherosclerosis in nongrafted arteries 5 years after coronary artery bypass surgery. Eur Heart J. 1998;19:711-719.
112. Lean ME, Han TS, Seidell JC. Impairment of health and quality of life in people with large waist circumference. Lancet. 1998;351:853-856.
113. Hill JO, Sidney S, Lewis CE, Tolan K, Scherzinger AL, Stamm ER. Racial differences in amounts of visceral adipose tissue in young adults: the CARD1A (Coronary Artery Risk Development in Young Adults) study. Am J Clin Nutr. 1999;69:381-387.
114. Rankinen T, Kim SY, Pèrusse L, Desprès JP, Bouchard C. The prediction of abdominal visceral fat level from body composition and anthropometry: ROC analysis. Int J Obes Relat Metab Disord. 1999;23:801-809.
115. Han TS, van Leer EM, Seidell JC, Lean ME. Waist circumference action levels in the identification of cardiovascular risk factors: prevalence study in a random sample. BMJ. 1995;311:1401-1405.